Sadiye Yolcu UYSAL, Nesrin Gökben ÇETİN, Önder TOMRUK

‘Paraparezi’,Metoklopramide Bağlı Nadir Bir Semptom mu?

Metoklopramid, üst gastrointestinal sistem motilitesini artırmak için kullanılan prokinetik ve antiemetik bir ajandır. Akut kas güçsüzlüğü ise acil serviste sık karşılaşılan nöromüsküler acillerden bir tanesidir ve etyolojisi çeşitlidir. Bizim bu çalışmamızda normal terapötik dozda metoklopramid tedavisi alan ve 12–24 saat içinde alt ekstremitede kas güçsüzlüğü gelişen olgu sunulmuş ve bu ilaca bağlı olası yan etkilerin gözden geçirilmesi amaçlanmıştır.

Anahtar Kelimeler:

Metoklopramid, Prokinetik Ajan, Nöromüsküler Aciller.

Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report

Metoclopramide is a procinetic and atiemetic agent, used to increase gastrintestinal system motility. In case, acute muscle weakness is one of the most neuromuscular emergencies seen in the emergency service and have several ethiological causes. In our study we aimed to introduce a case who was treated with metoclopramide in therapeutic dose and sustained muscle weakness in 12-24 hours and to overview the potential side effects of this drug

Keywords:

Metoclopramide, Procinetic Agent, Neuromuscular Emergencies,

PDF

___

Batts KF, Munter DW. Metoclopramid toxicity in an infant. Pedi- atr Emerg Care 1998;14: 39-41.
Bateman DN, Rawlins MD, Simpson JM. Extrapiramidal reac- tions with metoclopramide. BMJ 1985;291:930-932.
Guala A, Mittino D, Ghini T, Quazza G. Are metoclopramide dys- tonias familial? Pediatr Med Chir 1992;14:617-618.
Cohen SE,Woods WA, Wyner j, Antiemetic efficacy of droperidol and metoclopramide. Anaesthesiology 1984;60:6-69.
Jimenez-Jimenez FJ, Molina JA. Drug- induced movement disor- ders. Drug Safety 1997;16:180-204.
Hughes RAC, Rees JH. Clinical and epidemiological features of Guillain-Barré syndrome. J Infect Dis 1997;176:S92-S98.
Valenzuela JE, Dooley CP. Dopamine antagonists in the upper gas- trointestinal tract. Scand J Gastroenterol Suppl 1984;96:127-36.
Massara F, Tangolo D, Godano A, Goffi S, Bertagna A, Molinatti GM. Effect of metoclopramide, domperidone, and apomorphine on GH secretion in children and adolescents. Acta Endocrinol 1985;108:451-5.
Jolliet P, Nion S, Allain-Veyrac G, Tilloy-Fenart L, Vanuxeem D, Cecchelli R. Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood–brain barrier. Pharmacol Res 2007;56:11-17.
Parlak I, Erdur B, Parlak M, Ergin A, Turkcuer I, Tomruk O, et al. Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects? Postgrad Med J 2007;83:664-668.
tone AG, Howell PR. An unusual complication of metoclopramide injection. Anaesthesia. 2003;58:817-8.
Dingli K, Morgan R, Leen C.Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ. 2007;334:899-900.
Moos DD, Hansen DJ. J Perianesth Nurs. Metoclopramide and ex- trapyramidal symptoms: a case report. 2008;23:292-9.